The Aspirin Dilemma: ATTACK Trial Challenges Primary Prevention Paradigm in Chronic Kidney Disease
DENVER — For over a century, aspirin has been the cornerstone of cardiovascular medicine. Since its commercial debut in 1899, the antiplatelet agent has been lauded for its ability to…











